Form4insider filings, from the source

SEC Form 4 · accession 0001852291-26-000005

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lai Wang
Officer — President, Global Head of R&D
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 5:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Jun 11, 2026A118,625$0.00A1,710,085D
American Depositary SharesF6,F8Jun 11, 2026S756$261.0021D0D
Ordinary SharesF2holding———601,965ISee Footnote
RMB SharesF3,F4,F5holding———0ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Share Option (Right to Buy)F9,F10$20.81Jun 11, 2026A229,775A—Jun 10, 2036Ordinary Shares229,775229,775D

Explanation of responses